unaids8h
New long-acting HIV prevention options for women and girls in an era of choice
This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...
unaids13h
Women living with HIV in China unite to confront discrimination
In order to counter such stigma and discrimination, women living with HIV and Hepatitis B came together at The Voice of ...
unaids4d
Take the rights path - World AIDS Day 2024
Главная страница 2024 World AIDS Day — Take the rights path ...
unaids6d
UNAIDS response to ViiV’s announcement on increasing production of long-acting cabotegravir
Note: ViiV’s announcement can be read on their site at ...
unaids6d
News Feed
unaids.org UNAIDS There are around 1.4 million people living with HIV in China and women make up around 23.
unaids6d
long-acting technologies
GENEVA, 8 October 2024—Responding to ViiV’s announcement on long-acting cabotegravir , UNAIDS Executive Director Winnie Byanyima said: “New HIV prevention medication, in the form of a long-acting ...
unaids8d
Sam Kambarami Director, Finance and Accountability
Sam Kambarami is the Director, Finance and Accountability. He joined UNAIDS in September 2024 from the UN Climate Change/ United Nations Framework Convention on Climate Change (UNFCCC) secretariat ...
unaids11d
ONUSIDA advierte que el estigma y la discriminación asociados al VIH impiden que la población acceda a servicios relacionados con dicho virus
Un nuevo informe publicado por ONUSIDA aporta pruebas y pone de relieve las mejores prácticas para combatir el estigma y la discriminación a fin de garantizar el acceso a servicios de salud GINEBRA, 3 ...